hp | np Health

Home / Hormone health

Hormone Health & Women’s Psychiatry

Psychiatric care for mood, anxiety, sleep, and cognitive symptoms associated with the menstrual cycle, perimenopause, and menopause.

A woman with long silver hair in a sunlit room beside white orchids
Psychiatric evaluation
Mood, anxiety, attention & cognition
Symptom patterns
Cycle and reproductive-stage timing
Sleep & function
Daily impact and contributing factors
Integrated treatment
Psychiatric care with hormone therapy when appropriate

The Transition Deserves Attention

Hormonal changes across the reproductive lifespan can affect mood, anxiety, sleep, attention, and cognition. Symptoms may emerge before menstruation, worsen during perimenopause, or change after menopause.

These changes can resemble a new psychiatric disorder or intensify an existing condition such as depression, anxiety, ADHD, or a sleep disorder. A careful timeline helps distinguish PMDD, premenstrual exacerbation, perimenopausal symptoms, medication effects, and other medical or psychiatric contributors.

Evaluation at hp | np Health considers psychiatric symptoms together with menstrual patterns, reproductive stage, medical history, current medications, and functional impact. Hormone therapy may be considered when clinically appropriate, but it is not assumed to be the cause, or the treatment, for every symptom.

Clinical Scope

Conditions evaluated within a comprehensive women’s psychiatric assessment

  • Premenstrual Dysphoric Disorder (PMDD)
  • Premenstrual Exacerbation of Depression or Anxiety
  • Perimenopausal Depression & Anxiety
  • Irritability & Emotional Lability
  • Sleep Disturbance
  • Brain Fog & Concentration Changes
  • Psychiatric Symptoms During Menopause

The Role of Hormone Therapy in Psychiatric Care

One part of care

For appropriate candidates, FDA-approved menopausal hormone therapy may be considered as one part of care for symptoms associated with perimenopause or menopause. Treatment may also include psychiatric medication, psychotherapy, sleep-focused care, or coordination with primary care or gynecology. Pellet therapy is not offered.

What may be prescribed

When clinically indicated, hp | np Health may prescribe FDA-approved estradiol formulations and oral micronized progesterone. Testosterone may be considered selectively after assessment and informed consent; no testosterone formulation is FDA-approved specifically for women in the United States. Compounded hormones are not used as a first-line approach, and pellet therapy is not offered.

A note on safety: All hormone therapy decisions are made collaboratively, with full informed consent and a thorough review of your symptoms, medical history, contraindications, current medications, and relevant risk factors. Follow-up focuses on clinical response, tolerability, safety, and whether continued treatment remains appropriate.

Hormonal Change Can Shape Psychiatric Symptoms

Shifts in estrogen and progesterone can interact with brain systems involved in mood, stress response, sleep, and cognition. The clinical goal is not to attribute every symptom to hormones, but to understand when reproductive changes are an important part of the psychiatric picture.

Mood & Anxiety

New or worsening depression, anxiety, panic, irritability, or emotional reactivity may follow a cyclical pattern or emerge during perimenopause. Timing, severity, prior psychiatric history, and functional impact guide the differential diagnosis.

Sleep Disturbance

Insomnia, nighttime waking, vasomotor symptoms, and disrupted sleep can worsen mood regulation, anxiety, attention, and daytime functioning. Assessment considers both hormonal and nonhormonal causes of poor sleep.

Attention & Cognition

Brain fog, forgetfulness, reduced concentration, and executive-function difficulties are common concerns during hormonal transitions. Evaluation also considers ADHD, depression, anxiety, sleep loss, medication effects, thyroid disease, and other contributors.

Cycle-Linked Symptoms

PMDD and premenstrual exacerbation can look similar but require different clinical reasoning. Daily symptom tracking across at least two menstrual cycles may help clarify whether symptoms are confined to the luteal phase or represent worsening of an underlying disorder.

Hormone therapy is one possible intervention, not a universal psychiatric treatment. Recommendations are based on the working diagnosis, symptom pattern, reproductive stage, medical suitability, available evidence, and shared decision-making.

Psychiatric Care Through Hormonal Transitions

New patients start with a few questions below. Depending on your answers, you choose an open time right away, or your request is reviewed first and a follow-up will be sent. You can also begin with a brief inquiry through the contact form. Appointments are booked at least one week in advance.

  1. Comprehensive Intake, 90 minutes

    Psychiatric Evaluation

    Your first visit reviews current symptoms, psychiatric and medical history, menstrual and reproductive patterns, medications, sleep, and the effect of symptoms on daily functioning.

  2. During evaluation

    Diagnostic Clarification

    The assessment considers PMDD, premenstrual exacerbation, perimenopausal mood or anxiety symptoms, primary psychiatric conditions, sleep disorders, medication effects, and relevant medical contributors. Prior records or targeted testing may be reviewed when clinically indicated.

  3. Your care plan

    Evidence-Based Treatment

    Treatment is based on the working diagnosis and may include psychiatric medication, hormone therapy for appropriate candidates, psychotherapy recommendations, symptom tracking, sleep interventions, or coordination with other clinicians.

  4. Follow-Up visits, 40 minutes

    Clinical Follow-Up

    Follow-up evaluates symptom change, functioning, medication or hormone tolerability, and safety. Treatment is continued, adjusted, or reconsidered according to clinical response and current evidence.

New client questions

  • Comprehensive Intake, 90 minutes
  • In office in Elma, or telehealth in New York
  • Book at least one week ahead
  • Adults 18 and older

Loading the new client questions…

The questions didn’t load just now

Please call (716) 317-4537, or send an inquiry and a follow-up will be sent. You can also open the questions in a new window.

Call (716) 317-4537

Rather talk to someone? (716) 317-4537

Already a patient? Book follow-ups in your patient portal

Prefer to ask a question first? Send an inquiry and a follow-up will be sent.

Start Your Journey to Wellbeing

If you’re seeking greater clarity and balance in your health and well-being, please complete the short form to get started.

In-person office

Transit Commons Office Park
2711 Transit Road, Suite 124
Elma, NY 14059

Office in Elma, serving Buffalo and Western New York.

Get directions

Telehealth

Secure telehealth is available statewide for patients located in New York at the time of their appointment.

Hours

Monday
8 AM–8 PM
Friday
9 AM–4 PM
Saturday
9 AM–1 PM

Phone (716) 317-4537
Fax (716) 219-0662

If you are in crisis, feeling suicidal, or experiencing a psychiatric emergency, please immediately call 911 or go to your closest emergency room, or call or text 988 (Suicide & Crisis Lifeline). This form is not monitored in real time and is not appropriate for urgent or emergency situations.

Send a Message

Please do not include sensitive health information in this form. This form is for general inquiries only.

Your information is never shared.